Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

AFFYMETRIX

WKN: 901198  ISIN: US00826T1088  Ticker-Symbol: AFF 
Aktie:
Branche
Biotechnologie
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AFFYMETRIX Chart 1 Jahr
1-Woche-Intraday-Chart
AFFYMETRIX 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
Taxe
3,950
3,970
27.05.

Aktuelle News zur AFFYMETRIX Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
22.05. 5
21.05. 10
HONG KONG -- (Marketwire) -- 05/21/12 -- Today, www.BollingerReport.com introduced featured coverage of Affymetrix, Inc. (NASDAQ: AFFX) and Coherent, Inc. (NASDAQ: COHR). Full research reports are...
Mehr lesen zu:
A Forward Look, The Year Ahead - Featured Research on Affymetrix, Inc. and Coherent, Inc.
17.05. -
17.05. -
17.05. 22
Affymetrix releases first CTC platform for 4-color RNA-ISH Combination of ScreenCell's isolation devices and Affymetrix' QuantiGene® ViewRNA ISH technology...
Mehr lesen zu:
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology
11.05. 32
Affymetrix, Inc. (Nasdaq:AFFX) today invited investors and interested parties to hear a live webcast of its Annual Shareholder Meeting at 8:00am PT on Friday, May 11th...
Mehr lesen zu:
Affymetrix to Webcast Annual Meeting of Shareholders
09.05. 42
Morgan Stanley stuft Affymetrix von underweight auf equal weight. (© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
Morgan Stanley stuft Affymetrix von underweight auf equal weight.
08.05. 10
04.05. 7
04.05. 10
04.05. 99
WASHINGTON (dpa-AFX) - Affymetrix, Inc., (AFFX) and eBioscience, Inc. announced they have amended their existing definitive agreement. Under the terms of the amended agreement, Affymetrix...
Mehr lesen zu:
Affymetrix To Buy EBioscience For $315 Mln Cash Under Amended Deal Terms
04.05. 8
04.05. 77
Affymetrix, Inc., (NASDAQ:AFFX) and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay...
Mehr lesen zu:
Affymetrix and eBioscience Amend Definitive Merger Agreement
03.05. 43
WASHINGTON (dpa-AFX) - Technology company Affymetrix, Inc., (AFFX) reported a first-quarter net loss of $4.2 million, compared to a net income of $39 thousand in the previous year quarter....
Mehr lesen zu:
Affymetrix Slips To Loss In Q1
03.05. 15
Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the first quarter of 2012. Total revenue for the quarter was $65.2 million, as compared to total...
Mehr lesen zu:
Affymetrix Reports First Quarter 2012 Results
17.04. 43
Affymetrix, Inc. (NASDAQ: AFFX) today announced that its first quarter 2012 operating results will be reported after market close on Thursday May 3, 2012. The company...
Mehr lesen zu:
Affymetrix to Host Conference Call on May 3, 2012 to Announce First Quarter 2012 Operating Results
03.04. 63
Ideal microarray solution for RNA expression profiling from formalin fixed paraffin embedded (FFPE) samples for cancer research applications Affymetrix...
Mehr lesen zu:
Affymetrix Announces a Global Distribution Agreement With Almac to Distribute Its Proprietary Xcel™ Array for Translational Research Applications
29.03. 17
Xcel™ array optimised for RNA expression profiling from Formalin Fixed Paraffin Embedded (FFPE) samples Almac today announced that it has signed...
Mehr lesen zu:
Almac and Affymetrix Announce a Global Distribution Agreement for Almac's Xcel™ Array
29.03. 2
29.03. 45
Ideal microarray solution for RNA expression profiling from formalin fixed paraffin embedded (FFPE) samples for cancer research applications Affymetrix...
Mehr lesen zu:
Affymetrix Announces a Global Distribution Agreement With Almac to Distribute Its Proprietary Xcel™ Array for Translational Research Applications
Seite: 1 2 Weiter>>
37 Nachrichten in den letzten 6 Monaten